Posts Tagged ‘Salix’
RTP Wrapup 9/18
Thursday, September 17, 2009, 7:13 pmSalix Pharmaceuticals watches its stock soar and Pozen takes action to broaden the scope of the company while GlaxoSmithKline waits for regulatory approval of two vaccines.
Salix soars on rifaximin data
Wednesday, September 16, 2009, 5:11 amSalix Pharmaceuticals, a Morrisville company that specializes in gastrointestinal treatments, has seen its shares rise nearly 50 percent in the past two days.
Investors rushed to trade the stock after Salix announced results from two late-stage studies Monday that showed rifaximin works better than placebo in treating non-constipation irritable bowel syndrome. Salix sells rifaximin for traveler’s diarrhea under the name Xifaxan.
RTP Wrapup 9/11
Thursday, September 10, 2009, 9:39 pmGlaxoSmithKline gets good news on its Cervarix vaccine and bad news on its blockbuster asthma treatment Advair, the N.C. Biotechnology Center prepares to build a $10.4 million expansion with the help of private donations and Quintiles Transnational gets ready for Clinical Research Education Day at N.C. Central University.
